Trials / Completed
CompletedNCT04208373
A Study to Assess the Effects of Itraconazole and Etravirine on JNJ-64417184 in Healthy Adult Participants
A Phase 1, Open-label, Fixed-sequence, 2-Panel Study to Assess the Effects of Itraconazole and Etravirine on the Single-dose Pharmacokinetics of JNJ-64417184 in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Janssen Research & Development, LLC · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The main purpose of this study is to evaluate the effects of itraconazole or etravirine on the single-dose pharmacokinetics (PK) of JNJ 64417184 in healthy adult participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JNJ-64417184 | JNJ 64417184 tablets will be administered orally. |
| DRUG | Itraconazole | Itraconazole capsules will be administered orally |
| DRUG | Etravirine | etravirine tables will be administered orally. |
Timeline
- Start date
- 2019-12-20
- Primary completion
- 2020-03-10
- Completion
- 2020-03-10
- First posted
- 2019-12-23
- Last updated
- 2025-02-03
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04208373. Inclusion in this directory is not an endorsement.